We use cookies to provide and improve our services. They allow us to remember some of our preferences and improve the overall site performance. View our Privacy policy.
What is it
The Australian Centre for Accelerating Diabetes Innovations (ACADI) invites you to join its 2022 Annual Partnering Summit held on World Diabetes Day at Melbourne Connect. In this one-day summit, come take a look at how to successfully translate diabetes research, as well as the challenges and opportunities with experts and industry speakers.
When
14/11/2022 9:30am - 4:30pm
Where

The Forum, Melbourne Connect

Free
Get tickets

ACADI Annual Partnering Summit

The Australian Centre for Accelerating Diabetes Innovations (ACADI) invites you to join its 2022 Annual Partnering Summit held on World Diabetes Day at Melbourne Connect. In this one-day summit, come take a look at how to successfully translate diabetes research, as well as the challenges and opportunities with an incredible lineup of experts and industry speakers.

Open to all, this is a free event with networking lunch and light refreshments included.

Presented to you by ACADI and the Targeted Translation Research Accelerator (TTRA) Program, powered by MTPConnect.

About ACADI

The Australian Centre for Accelerating Diabetes Innovations Research Centre (ACADI) was established through MRFF funding from the Australian Government’s Targeted Translation Research Accelerator (TTRA) program, delivered by MTPConnect.

ACADI is a virtual collaborative diabetes centre uniting more than 70 partners spanning all Australian States and Territories and four international sites. Led by Associate Professor Elif Ekinci, Sir Edward Weary Dunlop Principal Research Fellow in Metabolic Medicine and Dame Kate Campbell Fellow at the University of Melbourne, ACADI includes Academic Partners, Advocacy Groups, Health Services and Industry Partners with a shared vision to benefit people with diabetes at each stage from diagnosis through to its devastating complications.

Our purpose is to deliver novel interventions for timely diagnosis, prevention and treatment of diabetes and its complications. Our research and development platform, national training program, and sustainable model will increase quality of life and life expectancy for all Australians living with diabetes and its complications. Furthermore, ACADI specifically addresses equity in diabetes related healthcare with targeted initiatives to ensure all Australians, regardless of their geographic location or cultural background, have equal access to innovative products and clinical trials.

Our diverse portfolio of projects aligns with our three Priority Areas:

  1. Diabetic kidney disease
  2. Peripheral neuropathy and diabetic foot syndrome
  3. Short-term complications of hypoglycaemia and/or hyperglycaemic hyperosmolar syndrome (HHS) and diabetic ketoacidosis (DKA)